Decoy Therapeutics Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Decoy Therapeutics Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-06-30 was $0.00.
- Decoy Therapeutics Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-03-31 was $0.00.
- Decoy Therapeutics Inc. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $0.00.
- Decoy Therapeutics Inc. stock issued during period, value, conversion of convertible securities for fiscal 2018 was $1.37M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2022-03-25 | |
| 2020-06-30 | $0.00 10-Q · filed 2020-11-12 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $1.37M 10-K · filed 2020-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |